Identification of Rifampin-Resistant Mycobacterium tuberculosis Strains by Hybridization, PCR, and Ligase Detection Reaction on Oligonucleotide Microchips

ABSTRACT Three new molecular approaches were developed to identify drug-resistant strains of Mycobacterium tuberculosisusing biochips with oligonucleotides immobilized in polyacrylamide gel pads. These approaches are significantly faster than traditional bacteriological methods. All three approaches—hybridization, PCR, and ligase detection reaction—were designed to analyze an 81-bp fragment of the gene rpoB encoding the β-subunit of RNA polymerase, where most known mutations of rifampin resistance are located. The call set for hybridization analysis consisted of 42 immobilized oligonucleotides and enabled us to identify 30 mutant variants of the rpoB gene within 24 h. These variants are found in 95% of all mutants whose rifampin resistance is caused by mutations in the 81-bp fragment. Using the second approach, allele-specific on-chip PCR, it was possible to directly identify mutations in clinical samples within 1.5 h. The third approach, on-chip ligase detection reaction, was sensitive enough to reveal rifampin-resistant strains in a model mixture containing 1% of resistant and 99% of susceptible bacteria. This level of sensitivity is comparable to that from the determination of M. tuberculosis drug resistance by using standard bacteriological tests.

[1]  S. Siddiqi,et al.  Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods , 1985, Journal of clinical microbiology.

[2]  M. A. O'connell,et al.  Comparison of mycobacteria growth indicator tube with BACTEC 460 for detection and recovery of mycobacteria from clinical specimens , 1996, Journal of clinical microbiology.

[3]  F. Portaels,et al.  Drug resistant tuberculosis in prisons in Azerbaijan: case study , 1998, BMJ.

[4]  C. Abe,et al.  Mutations in the rpoB Gene of Rifampin-Resistant Mycobacterium tuberculosis Strains Isolated Mostly in Asian Countries and Their Rapid Detection by Line Probe Assay , 1999, Journal of Clinical Microbiology.

[5]  F. Portaels,et al.  Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  A. Troesch,et al.  Mycobacterium Species Identification and Rifampin Resistance Testing with High-Density DNA Probe Arrays , 1999, Journal of Clinical Microbiology.

[7]  J. T. Crawford,et al.  Characterization of rifampin-resistance in pathogenic mycobacteria , 1994, Antimicrobial Agents and Chemotherapy.

[8]  K. Waites,et al.  Comparison of the MB/BacT System with a Revised Antibiotic Supplement Kit to the BACTEC 460 System for Detection of Mycobacteria in Clinical Specimens , 1998, Journal of Clinical Microbiology.

[9]  A. Mirzabekov,et al.  PCR amplification on a microarray of gel-immobilized oligonucleotides: detection of bacterial toxin- and drug-resistant genes and their mutations. , 2000, BioTechniques.

[10]  J. Musser,et al.  Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas , 1994, Journal of clinical microbiology.

[11]  A. Mirzabekov,et al.  DNA analysis and diagnostics on oligonucleotide microchips. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Inderlied,et al.  Detection of rifampin resistance in Mycobacterium tuberculosis by use of a rapid, simple, and specific RNA/RNA mismatch assay. , 1997, The Journal of infectious diseases.

[13]  S. Rüsch-Gerdes,et al.  Rapid detection of mycobacteria in clinical specimens by using the automated BACTEC 9000 MB system and comparison with radiometric and solid-culture systems , 1997, Journal of clinical microbiology.

[14]  R. Fontana,et al.  Reliability of the MB/BacT System for Testing Susceptibility of Mycobacterium tuberculosis Complex Isolates to Antituberculous Drugs , 2000, Journal of Clinical Microbiology.

[15]  A. Telenti,et al.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis , 1993, The Lancet.

[16]  F. Drobniewski,et al.  A national audit of the laboratory diagnosis of tuberculosis and other mycobacterial diseases within the United Kingdom. , 1999, Journal of clinical pathology.

[17]  P. V. van Helden,et al.  Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. , 1999, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  J. Musser,et al.  Antimicrobial agent resistance in mycobacteria: molecular genetic insights , 1995, Clinical microbiology reviews.

[19]  D. Persing,et al.  Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting , 1995, Journal of clinical microbiology.

[20]  Nalin Rastogi,et al.  Drug susceptibility testing in tuberculosis: a comparison of the proportion methods using Lowenstein-Jensen, Middlebrook 7H10 and 7H11 agar media and a radiometric method. , 1989, Research in microbiology.

[21]  Sreevatsan,et al.  Comparative Evaluation of Cleavase Fragment Length Polymorphism With PCR-SSCP and PCR-RFLP to Detect Antimicrobial Agent Resistance in Mycobacterium tuberculosis. , 1998, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

[22]  P. de Rijk,et al.  Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin , 1997, Antimicrobial agents and chemotherapy.

[23]  I. M. Medvedeva,et al.  Drug-resistant strains of Mycobacterium tuberculosis isolated in Russia. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[24]  D E Snider,et al.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. , 1995, JAMA.

[25]  J. T. Crawford,et al.  The resurgence of tuberculosis: is your laboratory ready? , 1993, Journal of clinical microbiology.

[26]  A. Berno,et al.  Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. , 1998, Genome research.

[27]  M. Raviglione,et al.  Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  A. Mirzabekov,et al.  Portable System for Microbial Sample Preparation and Oligonucleotide Microarray Analysis , 2001, Applied and Environmental Microbiology.

[29]  A. Mirzabekov,et al.  Integration of multiple PCR amplifications and DNA mutation analyses by using oligonucleotide microchip. , 2001, Analytical biochemistry.

[30]  A. Mirzabekov,et al.  Parallel thermodynamic analysis of duplexes on oligodeoxyribonucleotide microchips. , 1998, Nucleic acids research.

[31]  Albert Balows,et al.  Manual of Clinical Microbiology, 7th ed. , 2000 .

[32]  K. Castro,et al.  Trends in drug-resistant tuberculosis in the United States, 1993-1996. , 1997, JAMA.

[33]  M. Gismondo,et al.  Multicenter Evaluation of the Mycobacteria Growth Indicator Tube for Testing Susceptibility of Mycobacterium tuberculosis to First-Line Drugs , 1999, Journal of Clinical Microbiology.